Siloton

Siloton develops miniature optical coherence tomography chips to improve eye imaging and retinal disease monitoring.

Bristol, UK—Founded 2020—Website

£1.3MTotal raised

Siloton is a Bristol-based health technology start-up developing miniature optical coherence tomography chips for eye imaging. The firm aims to make retinal disease monitoring more accessible for patients and healthcare providers.

Team

Alasdair Price

CEO

Euan Allen

CTO

Ben Hunt

Chief Commercial Officer

Investors

Seed18 October 2024
£860K
EF
Evenlode Foundation
SA
Southeast Angels
FC
Francis Crick Institute
Innovate UK
Seed15 March 2022
£470K
QE
Quantum Exponential GroupLead
EI
Evenlode ImpactLead
MT
Michael Tibbets
ZŁ
Zbigniew Łukasiak
NH
Nick Holzherr
GJ
Grzegorz Jakacki
PM
Priyanka Mandal
DS
Darshak Shah

Funding history

Seed18 October 2024

£860K

Siloton secures £860k seed investment to advance commercialisation of its eye imaging chip technology.

The funding round was backed by Evenlode Foundation alongside angel investors and a grant from Innovate UK.

Seed15 March 2022

£470K

Siloton secures £470k in seed funding led by Quantum Exponential Group and Evenlode Impact to develop diagnostic imaging technology

The seed round was led by Quantum Exponential Group and Evenlode Impact to support diagnostic imaging development.